1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

Company Promotions Are The Latest Trend! MSLP, AMD; RHT Launces ELS: PennyGovernance.com

the fastest growing nutritional supplement companies in the US with a proprietary formulation used in eight performance products, the appointment of Mariel Selbovitz, MPH, as Director of Global Therapeutics Product Procurement Development.

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Aug 23, 2010 -
MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, today announced the appointment of Mariel Selbovitz, MPH, as Director of Global Therapeutics Product Procurement Development.

“We are thrilled to have Ms. Selbovitz join the MusclePharm team as we enter the therapeutic, nutritional supplementation market that is focused on products to meet the nutritional requirements of people living with HIV/AIDS,” stated Cory Gregory, MusclePharm’s President. “MusclePharm is working to greatly expand our sales of therapeutic, nutritional supplementation and provide increased help to people in need across the globe.”

By securing procurement of the Global Fund and PEPFAR, MusclePharm will be able to distribute Recon and other supplements to millions of people with HIV/AIDS worldwide thru government funds. In July 2010, MusclePharm presented at the 18th International AIDS Conference on the benefits of Recon in people with HIV/AIDS, sponsored by the National Association of People with AIDS (NAPWA) and the AIDS Institute, both leading HIV legislative and advocacy organizations.

“With Ms. Selbovitz extensive experience and assistance we plan to reach millions of people living with HIV in developing nations,” stated Dr. Roscoe Moore, former United States Surgeon General, and Chief Science Director for MusclePharm. “Participating in programs such as the Global Fund and PEPFAR and will enable MusclePharm to help counteract some of the devastating effects of HIV related nutritional deficiencies which greatly affect the immune system, as well as the growth and retention of muscle mass.”

The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing institution that invests the world’s money to battle disease. To date, it has committed US$19.3 billion in 144 countries to support large-scale prevention, treatment and care programs against these three diseases.

PEPFAR was launched in 2003 by President George W. Bush, and is the largest effort by any nation to combat a single disease with $18 billion dollars dedicated to fight HIV/AIDS in developing nations over the five year period of 2003-2008. In the first five years of the program, PEPFAR focused on establishing and scaling up prevention, care and treatment programs. It achieved success in expanding access to HIV prevention, care and treatment in low-resource settings.



In a recent press release, the Red Hat (NYSE: RHT) team is excited to launch Extended Life Cycle Support (ELS) for Red Hat Enterprise Linux. This is an optional subscription offering that provides support for Red Hat Enterprise Linux for longer than its standard seven-year life cycle.

With Extended Life Cycle Support customers can receive limited software maintenance and technical support services for an additional three years, extending the life cycle of Red Hat Enterprise Linux to a full ten years. The seven-year life cycle of a Red Hat Enterprise Linux release generally applies to major versions, so, for example, the standard life cycle of Red Hat Enterprise Linux 3 runs from October 2003, when it was released, to October 2010. For customers who purchase ELS, which is sold as an add-on to an existing Red Hat Enterprise Linux subscription, the support life cycle can be extended to October 2013.

ELS offers benefit to customers who do not wish to upgrade to a newer version of Red Hat Enterprise Linux, perhaps because their systems and applications are still running well and do not warrant upgrading, or maybe because of contractual requirements. An important use for ELS will be in virtualized environments. One way to enable an old, stable system to run on modern hardware is to virtualize it. The virtualization software supports the modern hardware and is able to host the old system. With ELS, the old system has an even longer supported life cycle while taking advantage of the latest hardware.



AMD (NYSE: AMD) reported today the appointment of Donald Newell as vice president and Chief Technology Officer (CTO), Server. A distinguished engineer with more than 20 patents filed, Newell previously served as a senior principle engineer leading the System-on-Chip (SoC) and datacenter networking architecture groups within Intel Labs before joining AMD to lead its server roadmap and platform design programs.

As AMD Server CTO, Newell is responsible for the concept and definition of AMD’s long-term server roadmap based on current conditions, expected demand and long-term server trends. He is leading multiple worldwide teams and working alongside other AMD design and development teams to ensure successful transition of programs from design to market availability. Newell reports to Rick Bergman, senior vice president and general manager, AMD Products Group.



Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

--- end ---

Click to Share

Contact Email:
***@yahoo.com
Issued By:Anthony Bartley
Industry:Business, Finance, Stocks
Tags:, donald newell, extended life cycle support, global fund to fight aids, , ,
Last Updated:Aug 23, 2010
Shortcut:http://prlog.org/10879586
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share